Shares of biotech company Novavax jumped 13.3% after it reported data on its vaccine candidate for COVID-19. Analysts cautioned not to ...
News
- Wall Street rallies again; S&P 500 pulls within 2% of record
- Xencor: 2Q Earnings Snapshot
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $13.1 million in the period, which beat ...
- bioAffinity Technologies Announces Poster Presentation at CYTO 2020 Conference
SAN ANTONIO--(BUSINESS WIRE)-- #BioTech--bioAffinity Technologies, a privately held biotech company, today presented a poster explaining the ...
- Texas Biomed adds International Global Health Expert to Leadership Team
Newswise — SAN ANTONIO, TEXAS (Aug. 5, 2020) – As Texas Biomedical Research Institute continues its efforts to attract international attention and ...
- How gene editing a person's brain cells could be used to curb the opioid epidemic
... moonshot for the present generation of biomedical scientists. This article is republished from The Conversation under a Creative Commons license.